S&P 500   3,004.52 (+0.28%)
DOW   26,833.95 (+0.17%)
QQQ   192.22 (+0.19%)
AAPL   243.18 (+1.34%)
FB   186.19 (+2.11%)
MSFT   137.24 (+0.64%)
GOOGL   1,257.63 (+1.32%)
AMZN   1,762.17 (-0.20%)
CGC   21.75 (+2.84%)
NVDA   195.09 (-0.27%)
MU   44.66 (+0.00%)
BABA   169.92 (+0.02%)
GE   9.14 (+0.88%)
TSLA   254.68 (-0.35%)
AMD   31.36 (-0.48%)
T   37.74 (-1.13%)
F   9.21 (+1.54%)
ACB   3.67 (+2.51%)
PRI   125.75 (-0.04%)
NFLX   271.27 (+1.72%)
BAC   31.42 (+0.71%)
GILD   66.58 (+1.09%)
DIS   131.13 (-0.96%)
S&P 500   3,004.52 (+0.28%)
DOW   26,833.95 (+0.17%)
QQQ   192.22 (+0.19%)
AAPL   243.18 (+1.34%)
FB   186.19 (+2.11%)
MSFT   137.24 (+0.64%)
GOOGL   1,257.63 (+1.32%)
AMZN   1,762.17 (-0.20%)
CGC   21.75 (+2.84%)
NVDA   195.09 (-0.27%)
MU   44.66 (+0.00%)
BABA   169.92 (+0.02%)
GE   9.14 (+0.88%)
TSLA   254.68 (-0.35%)
AMD   31.36 (-0.48%)
T   37.74 (-1.13%)
F   9.21 (+1.54%)
ACB   3.67 (+2.51%)
PRI   125.75 (-0.04%)
NFLX   271.27 (+1.72%)
BAC   31.42 (+0.71%)
GILD   66.58 (+1.09%)
DIS   131.13 (-0.96%)
Log in

Acrux Stock Price, News & Analysis (ASX:ACR)

A$0.22
+0.04 (+21.62 %)
(As of 10/23/2019 04:00 PM ET)
Today's Range
A$0.21
Now: A$0.23
A$0.23
50-Day Range
A$0.18
MA: A$0.18
A$0.23
52-Week Range
A$0.16
Now: A$0.23
A$0.26
Volume244,453 shs
Average Volume188,859 shs
Market Capitalization$37.51 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Acrux Limited, together with its subsidiaries, develops and commercializes specialty and generic topical pharmaceuticals in Australia, Switzerland, the United States, and internationally. The company offers testosterone solutions, such as oral tablets, buccal tablets, subcutaneous pellets, transdermal patches, injections, and topical gels for treatment of adult males who have low or no testosterone. It also provides estradiol sprays for women under the Evamist and Lenzetto brand names for the treatment of flushes associated with menopause. The company was founded in 1998 and is based in West Melbourne, Australia.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+61-3-83790100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$5.29 million
Cash FlowA$0.14 per share
Book ValueA$0.13 per share

Profitability

Miscellaneous

EmployeesN/A
Market Cap$37.51 million
Next Earnings DateN/A
OptionableNot Optionable

Receive ACR News and Ratings via Email

Sign-up to receive the latest news and ratings for ACR and its competitors with MarketBeat's FREE daily newsletter.


Acrux (ASX:ACR) Frequently Asked Questions

What is Acrux's stock symbol?

Acrux trades on the ASX under the ticker symbol "ACR."

Has Acrux been receiving favorable news coverage?

News headlines about ACR stock have trended somewhat positive on Wednesday, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Acrux earned a news impact score of 0.9 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for Acrux.

Who are some of Acrux's key competitors?

What other stocks do shareholders of Acrux own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Acrux investors own include Australia and New Zealand Banking Group (ANZ), Lynas (LYC), Altium (ALU), Atlas Iron (AGO), FlexiGroup (FXL), Fortescue Metals Group (FMG), Downer EDI (DOW), BHP Group (BHP), Billabong (BBG) and Ausdrill (ASL).

Who are Acrux's key executives?

Acrux's management team includes the folowing people:
  • Mr. Michael Kotsanis B.Sc., BSc, GradDipBus, MBus, CEO, MD & Exec. Director (Age 53)
  • Mr. Tim Bateman, CFO & Company Sec.
  • Ms. Felicia Colagrande BSc (Hons), MBA, Product Devel. & Technical Affairs Director
  • Mr. Charles O'Sullivan B. Pharm, Grad. Dip. Epi. & Biostats, Portfolio Director

What is Acrux's stock price today?

One share of ACR stock can currently be purchased for approximately A$0.23.

How big of a company is Acrux?

Acrux has a market capitalization of $37.51 million and generates $5.29 million in revenue each year. View Additional Information About Acrux.

What is Acrux's official website?

The official website for Acrux is http://www.acrux.com.au/.

How can I contact Acrux?

Acrux's mailing address is 103-113 Stanley St, MELBOURNE, VIC 3003, Australia. The company can be reached via phone at +61-3-83790100.


MarketBeat Community Rating for Acrux (ASX ACR)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  90 (Vote Outperform)
Underperform Votes:  80 (Vote Underperform)
Total Votes:  170
MarketBeat's community ratings are surveys of what our community members think about Acrux and other stocks. Vote "Outperform" if you believe ACR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ACR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/23/2019 by MarketBeat.com Staff

Featured Article: What are gap-down stocks?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel